{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:08:07Z","timestamp":1789553287624,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100015388","name":"Universit\u00e9 de Tunis El Manar","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015388","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-026-03262-7","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:47:23Z","timestamp":1789552043000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genomic surveillance of SARS-CoV-2 in Tunisia during the omicron era: insights from the national influenza & other respiratory viruses laboratory"],"prefix":"10.1186","volume":"23","author":[{"given":"Zaineb","family":"Hamzaoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Ferjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takoua","family":"Bouchouicha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latifa","family":"Charaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichrak","family":"Landolsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Medini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roua","family":"Ben Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarra","family":"Chammam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma","family":"Abid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamia","family":"Kanzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouna","family":"Ben Sassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameh","family":"Trabelsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilhem","family":"Boutiba Ben Boubaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"3262_CR1","unstructured":"World Health Organization. Update on Omicron [Internet]. Report No. Available from: https:\/\/www.who.int\/news\/item\/28-11-2021-update-on-omicron?utm_source=chatgpt.com"},{"issue":"8","key":"3262_CR2","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/s41564-022-01143-7","volume":"7","author":"BJ Willett","year":"2022","unstructured":"Willett BJ, Grove J, MacLean OA, Wilkie C, De Lorenzo G, Furnon W, et al. SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. Nat Microbiol. 2022;7(8):1161\u201379. https:\/\/doi.org\/10.1038\/s41564-022-01143-7.","journal-title":"Nat Microbiol"},{"issue":"7923","key":"3262_CR3","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-022-05053-w","volume":"608","author":"Q Wang","year":"2022","unstructured":"Wang Q, Guo Y, Iketani S, Nair MS, Li Z, Mohri H, et al. Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5. Nature. 2022;608(7923):603\u20138. https:\/\/doi.org\/10.1038\/s41586-022-05053-w.","journal-title":"Nature"},{"issue":"3","key":"3262_CR4","doi-asserted-by":"publisher","first-page":"954","DOI":"10.31662\/jmaj.2025-0118","volume":"8","author":"Anomalous Spike Mutations and Sporadic Global","year":"2025","unstructured":"Anomalous Spike Mutations and Sporadic Global. Detection of the SARS-CoV-2 BA.2.86 Lineage. JMA J. 2025;8(3):954\u201360. https:\/\/doi.org\/10.31662\/jmaj.2025-0118.","journal-title":"JMA J"},{"issue":"2","key":"3262_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1556\/030.2024.02247","volume":"71","author":"Z Hamzaoui","year":"2024","unstructured":"Hamzaoui Z, Ferjani S, Kanzari L, Ben Ali R, Charaa L, Landolsi I, et al. Unveiling the emergence of SARS-CoV-2 JN.1 sub-variant: Insights from the first cases at Charles Nicolle Hospital, Tunisia. Acta Microbiol Immunol Hung. 2024;71(2):165\u201371. https:\/\/doi.org\/10.1556\/030.2024.02247.","journal-title":"Acta Microbiol Immunol Hung"},{"issue":"1","key":"3262_CR6","doi-asserted-by":"publisher","first-page":"7003","DOI":"10.1038\/s41467-022-33713-y","volume":"13","author":"AF Brito","year":"2022","unstructured":"Brito AF, Semenova E, Dudas G, Hassler GW, Kalinich CC, Kraemer MUG, et al. Global disparities in SARS-CoV-2 genomic surveillance. Nat Commun. 2022;13(1):7003. https:\/\/doi.org\/10.1038\/s41467-022-33713-y.","journal-title":"Nat Commun"},{"issue":"9","key":"3262_CR7","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/s41587-021-01040-0","volume":"39","author":"K Kalia","year":"2021","unstructured":"Kalia K, Saberwal G, Sharma G. The lag in SARS-CoV-2 genome submissions to GISAID. Nat Biotechnol. 2021;39(9):1058\u201360. https:\/\/doi.org\/10.1038\/s41587-021-01040-0.","journal-title":"Nat Biotechnol"},{"key":"3262_CR8","doi-asserted-by":"publisher","first-page":"105405","DOI":"10.1016\/j.meegid.2023.105405","volume":"108","author":"S Tosta","year":"2023","unstructured":"Tosta S, Moreno K, Schuab G, Fonseca V, Segovia FMC, Kashima S, et al. Global SARS-CoV-2 genomic surveillance: What we have learned (so far). Infect Genet Evol. 2023;108:105405. https:\/\/doi.org\/10.1016\/j.meegid.2023.105405.","journal-title":"Infect Genet Evol"},{"key":"3262_CR9","unstructured":"Centers for Disease Control and Prevention. CDC\u2019s Influenza SARS-CoV-2 Multiplex Assay [Internet]. 2020. Report No. Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/lab\/multiplex.html"},{"key":"3262_CR10","unstructured":"FTD Respiratory Assays Syndromic Solutions. Respiratory Infections. Siemens Healthcare Diagnostics Inc [Internet]. Report No. Available from: https:\/\/www.siemens-healthineers.com\/molecular-diagnostics\/molecular-diagnostics-in-vitro-diagnostics\/ftd-respiratory-assays"},{"issue":"4","key":"3262_CR11","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41588-022-01033-y","volume":"54","author":"Z Chen","year":"2022","unstructured":"Chen Z, Azman AS, Chen X, Zou J, Tian Y, Sun R, et al. Global landscape of SARS-CoV-2 genomic surveillance and data sharing. Nat Genet. 2022;54(4):499\u2013507. https:\/\/doi.org\/10.1038\/s41588-022-01033-y.","journal-title":"Nat Genet"},{"issue":"1","key":"3262_CR12","doi-asserted-by":"publisher","first-page":"e2365","DOI":"10.1002\/rmv.2365","volume":"33","author":"H Krumbein","year":"2023","unstructured":"Krumbein H, K\u00fcmmel LS, Fragkou PC, Th\u00f6lken C, H\u00fcnerbein BL, Reiter R, et al. Respiratory viral co-infections in patients with COVID\u201019 and associated outcomes: A systematic review and meta\u2010analysis. Rev Med Virol. 2023;33(1):e2365. https:\/\/doi.org\/10.1002\/rmv.2365.","journal-title":"Rev Med Virol"},{"key":"3262_CR13","doi-asserted-by":"publisher","unstructured":"Chow EJ, Uyeki TM, Chu HY. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol 2022 Oct 17. https:\/\/doi.org\/10.1038\/s41579-022-00807-9","DOI":"10.1038\/s41579-022-00807-9"},{"key":"3262_CR14","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ijid.2022.12.042","volume":"128","author":"F Bonacina","year":"2023","unstructured":"Bonacina F, Bo\u00eblle PY, Colizza V, Lopez O, Thomas M, Poletto C. Global patterns and drivers of influenza decline during the COVID-19 pandemic. Int J Infect Dis. 2023;128:132\u20139. https:\/\/doi.org\/10.1016\/j.ijid.2022.12.042.","journal-title":"Int J Infect Dis"},{"issue":"5","key":"3262_CR15","doi-asserted-by":"publisher","first-page":"e13140","DOI":"10.1111\/irv.13140","volume":"17","author":"L Staadegaard","year":"2023","unstructured":"Staadegaard L, Del Riccio M, Wiegersma S, El Guerche-S\u00e9blain C, Dueger E, Ak\u00e7ay M, et al. The impact of the SARS\u2010CoV\u20102 pandemic on global influenza surveillance: Insights from 18 National Influenza Centers based on a survey conducted between November 2021 and March 2022. Influenza Other Respir Viruses. 2023;17(5):e13140. https:\/\/doi.org\/10.1111\/irv.13140.","journal-title":"Influenza Other Respir Viruses"},{"key":"3262_CR16","doi-asserted-by":"publisher","first-page":"1029190","DOI":"10.3389\/fpubh.2022.1029190","volume":"10","author":"SA Kharroubi","year":"2022","unstructured":"Kharroubi SA, Diab-El-Harake M. Sex-differences in COVID-19 diagnosis, risk factors and disease comorbidities: A large US-based cohort study. Front Public Health. 2022;10:1029190. https:\/\/doi.org\/10.3389\/fpubh.2022.1029190.","journal-title":"Front Public Health"},{"issue":"1","key":"3262_CR17","doi-asserted-by":"publisher","first-page":"126","DOI":"10.21608\/mjmr.2022.150649.1124","volume":"34","author":"A Mohammed","year":"2023","unstructured":"Mohammed A, El Sharkawy E, Saber M, Zaki Z. Demographic data in COVID 19 patients. Minia J Med Res. 2023;34(1):126\u201332. https:\/\/doi.org\/10.21608\/mjmr.2022.150649.1124.","journal-title":"Minia J Med Res"},{"issue":"4","key":"3262_CR18","doi-asserted-by":"publisher","first-page":"890","DOI":"10.2337\/dc22","volume":"46","author":"R Li","year":"2023","unstructured":"Li R, Shen M, Yang Q, Fairley CK, Chai Z, McIntyre R, et al. Global Diabetes Prevalence in COVID-19 Patients and Contribution to COVID-19- Related Severity and Mortality: A Systematic Review and Meta-analysis. Diabetes Care. 2023;46(4):890\u20137. https:\/\/doi.org\/10.2337\/dc22-. 1943 PubMed PMID: 36826982; PubMed Central PMCID: PMC10090902.","journal-title":"Diabetes Care"},{"key":"3262_CR19","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.2147\/IDR.S451114","volume":"17","author":"MZ Wardak","year":"2024","unstructured":"Wardak MZ, Daanish AF, Mushkani EA, Atiq MA. Prevalence of Hypertension and Diabetes in Severe COVID-19: A Cross-Sectional Study from Single Center, Kabul. Infect Drug Resist. 2024;17:1677\u201383. https:\/\/doi.org\/10.2147\/IDR.S451114.","journal-title":"Infect Drug Resist"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-026-03262-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-026-03262-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-026-03262-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:47:25Z","timestamp":1789552045000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12985-026-03262-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3262"],"URL":"https:\/\/doi.org\/10.1186\/s12985-026-03262-7","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"13 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Nasopharyngeal swabs included in this analysis were collected as part of routine clinical care and national sentinel surveillance for COVID-19 and other respiratory viruses in Tunisia. No additional samples were obtained for research purposes. All data were fully anonymized before analysis, and results are reported in aggregate form without any identifiable personal information. According to national regulations and institutional policies governing the use of anonymized surveillance data, this work did not require formal review by an ethics committee and individual informed consent was not required. This exemption\/authorization was approved by the Tunisian Ministry of Health as part of the national surveillance framework.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors consented to the publication of this study.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"215"}}